This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 16, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Check out JMCM’s new website at www.jmcmpub.org

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S. Please click here to view the press release.

Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

Click here to view our Complimentary Online CME/CEU Webcasts

 

Next week: 2015 Spring Managed Care Forum

Register today for the 2015 Spring Forum being held April 23-24, 2015 at Disney's Yacht & Beach Club. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


Study sparks debate on accuracy of genome tests for cancer patients
The Wall Street Journal
A new study has triggered a dispute over the accuracy of genomic tests that are increasingly used to match cancer patients with drugs that attack their tumors. The study, published by researchers at Johns Hopkins Kimmel Cancer Center, suggests that such tests could lead doctors to prescribe an ineffective drug in up to half of cases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Genes may make 'placebo effect' stronger for some
HealthDay News
A new report suggests that the strength of your "placebo effect" may depend on your particular DNA. In clinical trials of new drugs, people who receive a fake treatment, or placebo, often feel relief from medical conditions and pain. A better understanding of this phenomenon — called the placebo effect — could improve medical research and healthcare, the authors of the new paper said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Scientists uncover gene 'architects' responsible for body's blueprint
Phys.org
Researchers have identified two key proteins that act as genetic "architects," creating the blueprint needed by embryos during the earliest stages of their development. Previous work by the research team from the Walter and Eliza Hall Institute in Melbourne, Australia, showed that the protein MOZ could relay external "messages" to the developing embryo, revealing a mechanism for how the environment could affect development in very early pregnancy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Heart chip beats toward better drug screening, personalized medicine
Reuters via Fox News
Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool for drug development as well as pave the way toward personalizing treatments for patients with heart conditions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


Yale launches national study of personalized medicine for metastatic melanoma
Yale News
Yale University has launched a multicenter clinical trial, sponsored by Stand Up to Cancer and Melanoma Research Alliance, that will apply the latest in personalized medicine technology to treat metastatic melanoma. The trial, for which Yale is a lead site, will enroll patients lacking a particular genetic mutation for whom immune therapy did not work or was not an option.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Fecal transplant, stem cells may help Crohn's disease
HealthDay News via CBS News
Two experimental therapies might help manage the inflammatory bowel disorder Crohn's disease, if this early research pans out. In one study, researchers found that a fecal transplant — stool samples taken from a healthy donor — seemed to send Crohn's symptoms into remission in seven of nine children treated.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




EMERGING MEDICAL TECHNOLOGIES


70 percent of physicians believe health IT decreased patient engagement
HIT Consultant
Despite U.S. doctors’ increased use of technology, more than two-thirds of them believe that health IT has decreased the amount of time they spend with patients, according to a new survey by Accenture. The findings revealed during HIMSS15 is part of a six-country survey of more than 2,600 physicians, believe that interoperability of the tools currently available limits their ability to improve the quality of patient care through healthcare IT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


3 technology trends transforming healthcare
Forbes
The healthcare industry has always been changing, but what is different about our industry now is that the pace of change has sped up. Keeping up with those changes is almost impossible. More so when day-to-day activity prevents leaders from strategic planning the next three to five year direction of their organization.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
SOAPware. Exceptional Software. Empowering Healthcare.
Ranked #1 in the Nation for Quality of Care. Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals! MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


ACCOUNTABLE CARE ORGANIZATIONS


5 changes to help Medicare ACOs thrive
FierceHealthcare
Despite the rapid growth and early successes of accountable care organizations, the Medicare Shared Savings Program must make some key changes to fully realize the model's potential, argues a Health Affairs blog post.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA warns researchers on claims of drug to detect brain disease
The New York Times
The developers of a new drug aimed at diagnosing chronic traumatic encephalopathy, a degenerative brain disease linked to repeated head trauma, are under scrutiny by the Food and Drug Administration. In February, the FDA’s Office of Prescription Drug Promotion sent a letter to two researchers at UCLA warning them that they had improperly marketed their drug on the Internet and had made overstated claims about the drug’s potential efficacy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA accused of dragging heels on dietary supplement dangers
Forbes
Recently, New York Times journalist Anahad O’Connor continued reporting on his investigation of the dietary supplement industry, this time calling into question the FDA’s apparent silence on a harmful amphetamine derivative in herbal products for weight loss, athletic performance, and mental concentration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Nearly 90 percent of Americans have health coverage
CNN Money
A poll by Gallup found that the uninsured rate among U.S adults declined to 11.9 percent in the first quarter, down one percentage point from the end of last year and an improvement from the 18 percent without insurance in the fall of 2013, when the Americans were first were able to sign up for coverage at state and federal exchanges.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Millennials, Gen Xers leading change in healthcare over seniors, boomers
By Scott E. Rupp
Millennials and Gen Xers are a population segment harboring and bringing about advances in healthcare technology. They are also altering the delivery of healthcare and insurance, according to new research offered up by PNC Healthcare. The trends identified in a survey of more than 5,000 people show that millennials, specifically, are impacting healthcare systems as we know them. They seek more speed and more knowledge before they buy, and they want to know the costs and other points.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Pulling the strings of our genetic puppetmasters: Engineers gain control of gene activity (Phys.org)
FDA offers guidance on developing opioids less prone to be abused (The Wall Street Journal)
ALS patients press FDA for quick access to controversial biotech drug (The Washington Post)
Human stem cells shape a new approach to autism research (LiveScience)
How biotech is revolutionizing personalized medicine (Wired via Genetic Literacy Project)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 9, 2015
April 2, 2015
March 26, 2015
March 19, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063